CMEO Webcast
Premiere Date: Friday, May 18, 2018
This activity offers CE credit for:
Physicians (CME)Nurses (CNE)Pharmacists (ACPE)ABIM (ABIM)OtherAll other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date: Saturday, May 18, 2019
Faculty
Andrew C. Charles, MD
Professor of Neurology
Meyer and Renee Luskin Chair in Migraine and Headache Studies
Director, Goldberg Migraine Program
David Geffen School of Medicine, University of California, Los Angeles
Los Angeles, CA
Grace Forde, MD
Director of Neurological Services
North American Partners in Pain Management, LLP
Lake Success, NY
Statement of Need
Migraine is a debilitating condition with profound effects on individuals’ quality of life, accounting for five to nine million primary care visits each year. It is estimated that 38% of sufferers could benefit from preventative treatment, but few are currently using them nor are their healthcare providers discussing these options with them. Consequently, there is great interest in emerging data about calcitonin gene-related peptide (CGRP) agents as novel options for migraine prevention and the benefits they may provide to patients.
In this CME Outfitters recorded symposium, expert faculty discuss the evidence for new agents, share strategies to address migraine prophylaxis, and translate evidence to real-world clinical practice utilizing case-based learning, which will optimize changes in practice for healthcare providers.
Learning Objectives
At the end of this CE activity, participants should be able to:
Apply knowledge of clinical features, symptoms, and key diagnostic criteria in the differential diagnosis of migraine.Assess safety and efficacy data supporting the role of agents that target CGRP in the prevention and management of migraine.Employ a patient-centered approach to the care of patients with migraine in order to improve outcomes, patient satisfaction, and treatment adherence.The following learning objectives pertain only to those requesting CNE or CPE credit:
Identify clinical features, symptoms, and key diagnostic criteria in the differential diagnosis of migraine.Explain safety and efficacy data supporting the role of agents that target CGRP in the prevention and management of migraine.Describe a patient-centered approach to the care of patients with migraine in order to improve outcomes, patient satisfaction, and treatment adherence.Financial Support
This activity is supported by an edu